ENFN - Enfusion Inc - H1 chart symbol - $ENFN - h1 chart shows strong demand recently when the insiders bought up over $46 million dollars worth of shares a few days ago. Lets see if this demand zone holds up
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.04 USD
6.33 M USD
174.53 M USD
49.54 M
About Enfusion, Inc.
Sector
Industry
CEO
Oleg Movchan
Website
Headquarters
Chicago
Founded
2006
FIGI
BBG012MBFQD7
Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. It is a software-as-a-service firm that develops a platform to eliminate technology and information barriers, and simplify investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset. The company was founded by Tarek Hammoud, Stephen M. Malherbe, Oleg Movchan, and Scott Werner in 2006 and is headquartered in Chicago, IL.
$ENFN is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $20,26;
stop-loss — $1
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ENFN is 10.71 USD — it has increased by 0.57% in the past 24 hours. Watch Enfusion, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Enfusion, Inc. stocks are traded under the ticker ENFN.
ENFN stock has fallen by −5.11% compared to the previous week, the month change is a 1.93% rise, over the last year Enfusion, Inc. has showed a 8.51% increase.
We've gathered analysts' opinions on Enfusion, Inc. future price: according to them, ENFN price has a max estimate of 13.00 USD and a min estimate of 8.00 USD. Watch ENFN chart and read a more detailed Enfusion, Inc. stock forecast: see what analysts think of Enfusion, Inc. and suggest that you do with its stocks.
ENFN reached its all-time high on Nov 15, 2021 with the price of 23.21 USD, and its all-time low was 7.37 USD and was reached on May 16, 2023. View more price dynamics on ENFN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ENFN stock is 2.29% volatile and has beta coefficient of 0.24. Track Enfusion, Inc. stock price on the chart and check out the list of the most volatile stocks — is Enfusion, Inc. there?
Today Enfusion, Inc. has the market capitalization of 998.46 M, it has decreased by −1.58% over the last week.
Yes, you can track Enfusion, Inc. financials in yearly and quarterly reports right on TradingView.
Enfusion, Inc. is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
ENFN earnings for the last quarter are 0.05 USD per share, whereas the estimation was 0.06 USD resulting in a −12.43% surprise. The estimated earnings for the next quarter are 0.06 USD per share. See more details about Enfusion, Inc. earnings.
Enfusion, Inc. revenue for the last quarter amounts to 51.17 M USD, despite the estimated figure of 52.17 M USD. In the next quarter, revenue is expected to reach 54.59 M USD.
ENFN net income for the last quarter is 1.42 M USD, while the quarter before that showed 1.83 M USD of net income which accounts for −22.51% change. Track more Enfusion, Inc. financial stats to get the full picture.
No, ENFN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 1.10 K employees. See our rating of the largest employees — is Enfusion, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Enfusion, Inc. EBITDA is 17.33 M USD, and current EBITDA margin is 11.77%. See more stats in Enfusion, Inc. financial statements.
Like other stocks, ENFN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Enfusion, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Enfusion, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Enfusion, Inc. stock shows the strong buy signal. See more of Enfusion, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.